CWG
PRCT icon

C WorldWide Group’s Procept Biorobotics PRCT Stock Holding History

C WorldWide Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.38M Hold
375,000
– – 0.2% 59
2025
Q4 		$11.8M Buy
375,000
+225,000
+150% +$7.46M 0.21% 55
2025
Q3 		$5.35M Buy
+150,000
New +$6.85M 0.08% 71

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

C WorldWide Group's PRCT Position: Q1 2026 in Review

C WorldWide Group held its Procept Biorobotics (PRCT) position steady in Q1 2026 at 375,000 shares worth $9.38M. The position accounts for 0.2% of the portfolio, ranked #59.

C WorldWide Group first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $11.8M in Q4 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • C WorldWide Group held 375,000 shares of Procept Biorobotics worth $9.38M as of Q1 2026.
  • C WorldWide Group left its Procept Biorobotics share count unchanged in Q1 2026.
  • Procept Biorobotics made up 0.2% of C WorldWide Group's portfolio in Q1 2026, its #59 holding.
  • C WorldWide Group first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • C WorldWide Group's Procept Biorobotics position peaked at $11.8M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on C WorldWide Group's 13F filing for Q1 2026, filed 6 May 2026.